Ameritas Investment Partners’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-4,805
| Closed | -$4.37K | – | 3266 |
|
2025
Q1 | $4.37K | Hold |
4,805
| – | – | ﹤0.01% | 2998 |
|
2024
Q4 | $13.3K | Hold |
4,805
| – | – | ﹤0.01% | 2814 |
|
2024
Q3 | $25.1K | Hold |
4,805
| – | – | ﹤0.01% | 2543 |
|
2024
Q2 | $21.4K | Hold |
4,805
| – | – | ﹤0.01% | 2581 |
|
2024
Q1 | $36.8K | Hold |
4,805
| – | – | ﹤0.01% | 2299 |
|
2023
Q4 | $20.5K | Buy |
4,805
+2,010
| +72% | +$8.56K | ﹤0.01% | 2574 |
|
2023
Q3 | $11.7K | Hold |
2,795
| – | – | ﹤0.01% | 2773 |
|
2023
Q2 | $15.6K | Buy |
+2,795
| New | +$15.6K | ﹤0.01% | 2695 |
|
2022
Q2 | – | Sell |
-692
| Closed | -$3K | – | 3150 |
|
2022
Q1 | $3K | Hold |
692
| – | – | ﹤0.01% | 3026 |
|
2021
Q4 | $5K | Hold |
692
| – | – | ﹤0.01% | 3039 |
|
2021
Q3 | $8K | Hold |
692
| – | – | ﹤0.01% | 2992 |
|
2021
Q2 | $12K | Hold |
692
| – | – | ﹤0.01% | 2902 |
|
2021
Q1 | $14K | Hold |
692
| – | – | ﹤0.01% | 2717 |
|
2020
Q4 | $14K | Hold |
692
| – | – | ﹤0.01% | 2648 |
|
2020
Q3 | $18K | Buy |
+692
| New | +$18K | ﹤0.01% | 2431 |
|